These studies show the importance of finding further biomarkers of tumor cells such as PD-1 and CTLA-4 and of tumor infiltrating immune cells such as T cells and Macrophages to improve new treatment strategies and to choose the best treatment strategy for osteosarcoma patients. Here, CTLA4 is linked to osteosarcoma.